| Name | Title | Contact Details |
|---|
gm3 is the leading web3-native professional services firm. We are dedicated to being the trusted partner of choice for companies and investors looking to navigate the exciting world of web3. Our mission is to provide expert consulting services that empower our clients to unlock the full potential of this transformative technology. gm3 Ventures connects Founders & Investors. For aspiring entrepreneurs, we offer a comprehensive range of financing services tailored to your specific needs. For investors, we provide access to diversified investment opportunities in the web3 ecosystem. With our rigorous due diligence process and curated network, we ensure quality deal flow. gm3 Research specializes in high-end, commissioned research and whitepaper curation across the web3, decentralized finance and technology spaces. Our commitment to excellence is led by Crypto Punk and Harvard University PhD, Dr. Michael Frisch. Together with our team of field experts, we illuminate the path to informed decision-making in the dynamic landscape of web3. gm3 Advisory provides tailored advice and strategic guidance to unlock the potential of web3 for both traditional companies exploring the space and web3-native companies looking to structure and scale their businesses. gm3 Curation offers luxury concierge services across physical art, digital art and high-end fashion. Our creative agency partnership has curated collections for some of the biggest high-end fashion brands in the world. The name gm3 stems from the ubiquitous gm (good morning) greeting that prevails in the decentralized finance & technology spaces. The number 3 represents the last digit in the term web3, which represents the 3rd major evolution of the internet.
Machines and Systems for Solid Wood Processing You can concentrate on your business, let us do everything else! WEINIG is not only the leading manufacturer for the solid wood processing industry, we lead this industry in technology and ideas! WEINIG offers comprehensive services and system solutions – all the way to complete turnkey production plants – making WEINIG the all-around ideal partner where the focus is always on flexible, profitable production.
In 1954, in a one-room machine shop in Augusta, Georgia, the first Textron Specialized Vehicles products were born. Two brothers started with a simple belief that they could build a better golf car, that better met the customers needs, than any other vehicle on the market. Since those beginnings, the Textron Specialized Vehicles product line includes not only golf cars, but also ground support equipment for the aviation industry, industrial utility vehicles, and recreational side-by-side UTVs. The company has become a world leader in transportation and a leading global manufacturer of golf cars, side-by-sides, utility vehicles, personal transportation vehicles and aviation ground support equipment. We build thousands of vehicles each year, many of which featuring game-changing technology and innovations to improve vehicle efficiency and enhance the user experience like no other vehicle can. Today, Textron Specialized Vehicles includes brands that are leaders in the respective industries they serve -- Cushman®, E-Z-GO®, Arctic Cat®, Jacobsen®, Ransomes®, TUG™, Douglas™, Premier™, and Safeaero™. Since 1960, the company has been part of Textron Inc. (NYSE: TXT), a global multi-industry company headquartered in Providence, RI. A Fortune 500 company with more than 35,000 employees worldwide and operations in 25 countries, Textron is known for its powerful brands, including E-Z-GO, Cessna, Beechcraft, Hawker, Bell, and Kautex, among others. But nearly 70 years after our first product was built in that one-room shop, there is still that single belief – that we exist to build vehicles and services that exceed customers expectations, better than any other offering on the market. It is the drive to sustain and improve that position – to offer an unparalleled combination of world-class products, advanced technology, manufacturing expertise, and extraordinary service – that leads Textron Specialized Vehicles to cover new ground.
Established in 2015, India based NODWIN Gaming nourishes the dynamic gaming & esports ecosystem both domestically and internationally. Fueled by innovative ideas and passion, the company brings expertise and solutions in all of the aspects within the broad label of the esports industry. From tournaments & events, through influencers & content, to marketing & activations. You name it. NODWIN Gaming makes it happen. The fresh perspectives presented by highly skilled team members and management engage and inspire players, spectators, and brands. NODWIN Gaming is constantly hungry and focused on making a global impact. The company invests in emerging markets around the world. Currently, its expansion has reached South Africa, South Asia and the UAE, but it wont stop there.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.